Clinical Trial: Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Malaria,Falciparum
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2a Single Centre, Randomised, Placebo-controlled, Double-blind, Dose-escalation, Age De-escalation, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Plasmodium Falcipar
Brief Summary:
Mali faces a significant challenge with malaria, particularly among its younger population.While existing measures like seasonal chemoprevention and vaccination have shown efficacy, further innovations are necessary to combat this disease.The monoclonal antibody TB31F shows promise in reducing the transmission of malaria.This clinical trial will evaluate the safety and efficacy of the monoclonal antibody TB31F.
Read more